Fierce Pharma

After scrapped trial, InflaRx could tap partner to revive development of COVID drug in rare skin disorder

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder

InflaRx presented data analyses from a terminated Phase 3 study on the potential treatment for rare skin condition.
Healio

First patient dosed in phase 3 vilobelimab trial for pyoderma gangrenosum

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ulcerative pyoderma gangrenosum is a rare disease with ...
TMCnet

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...
Zawya

BRIEF-XOMA says finalizing plans for gevokizumab phase 3 clinical program in pyoderma gangrenosum

Get insights and exclusive content from the world of business and finance that you can trust, delivered to your inbox.
KHQ

Spokane man with extremely rare condition perplexes nation's top doctors

SPOKANE, Wash. – Ryan Becker, a Spokane resident, is battling an extremely rare skin condition known as pyoderma gangrenosum. After visits to the Mayo Clinic and Johns Hopkins, Becker has been ...
Medscape

Pyoderma Gangrenosum in Pregnancy Often Misdiagnosed

A systematic review of 63 cases found that pyoderma gangrenosum (PG) during pregnancy or postpartum was often misdiagnosed, delaying treatment and leading to inappropriate interventions. Researchers ...
WGN Radio

Insurance regulations are now stopping a man with rare disease from getting the one drug saving his life: Ryan Becker’s story

“It looks like I’m going to die.”- Ryan Becker is the only known person to have all three subtypes of a rare disease called Pyoderma Gangrenosum. Ryan joins Steve Dale to discuss how insurance ...